What you'll learn

Biological therapies for IBD: how to choose which agent to start with? How to monitor during treatment? What is the role for therapeutic drug monitoring? When to switch? What new agents are now available?
Managing refractory pouchitis
GI complications of immunotherapy — a common and heterogeneous disorder: how to approach and treat effectively?
Antiviral therapies for hepatitis B and C: how to select which regimen to use? Understanding long-term risks of therapy
See the course registration details for additional topics

Course description

This is an accredited, livestreamed course offered by Massachusetts General Hospital, Brigham Health, and Beth Israel Deaconess Medical Center. This course is targeted to Gastroenterologists, Internists, Surgeons, Nurse Practitioners, Physician Assistants.

Select the Take Course button to view additional information on the course registration page.

Contact ceprograms@hms.harvard.edu with questions.

Learn More

Pulmonary and Critical Care Medicine 2026

Pulmonary and Critical Care Medicine 2026 offers a comprehensive update on state-of-the-art evaluation, diagnosis, treatment, and procedures for patients with common, rare, and challenging pulmonary conditions and for patients requiring critical care.

$1,375